This is the authors' abstract. We don't add key points for this paper.
Abstract —The uptake of l[14C]glutamine by a crude isolated nerve ending fraction of rat brain was found to be linear with time for at least 5 min, profoundly temperature‐dependent, apparently half‐saturated at a substrate concentration of 0·26 mm, partially inhibited by dinitrophenol and ouabain and elevated [K+], weakly Na+‐dependent, poorly inhibited by drugs which block uptake of biogenic amines and more strongly inhibited by glutamic acid (IC50= 0·5mm) than by aspartic acid, GABA, glycine or methionine. The [14C]glutamine taken up appeared to be associated with nerve endings and was released by membrane‐disruption; about 20 per cent was associated with free mitochondria. Glutamine, δ‐aminolevulinic acid and several other amino acids were poor inhibitors of [3H]GABA‐uptake; δ‐aminolevulinic acid was a poor inhibitor of [3H]glutamine‐uptake, whereas glutamine was a moderately effective competitive inhibitor (Ki= 1 mm). [14C]glutamine and [3H]GABA were released from brain slices by electrical stimulation or 50 mm K+, while labeled δ‐aminolevulinic acid, leucine, urea, amphetamine and tyramine were poorly released. [14C]glutamine was not released by unlabeled glutamate or several aromatic amines. We conclude that the neuropsychiatric features of porphyria are not likely due to a ‘false transmitter’ role for δ‐aminolevulinic acid although such a role for glutamine in hepatic encephalopathy or other neuropsychiatric diseases should be considered.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Baldessarini et al. (1974) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: